X4 Pharmaceuticals Liabilities 2024

X4 Pharmaceuticals Aktienanalyse

What does X4 Pharmaceuticals do?

X4 Pharmaceuticals Inc is a biopharmaceutical company founded in 2015 and based in Massachusetts. The company focuses on the discovery and development of new therapies for rare genetic diseases and cancer. X4 Pharmaceuticals ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Liabilities Details

Assessing X4 Pharmaceuticals's Liabilities

X4 Pharmaceuticals's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating X4 Pharmaceuticals's financial stability, operational efficiency, and long-term viability.

Year-to-Year Comparison

By comparing X4 Pharmaceuticals's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.

Impact on Investments

X4 Pharmaceuticals's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.

Interpreting Liability Fluctuations

Shifts in X4 Pharmaceuticals’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.

Frequently Asked Questions about X4 Pharmaceuticals Stock

What is the level of liabilities of X4 Pharmaceuticals this year?

X4 Pharmaceuticals has a debt balance of 96.16 M USD this year.

What were the liabilities of X4 Pharmaceuticals compared to the previous year?

The liabilities of X4 Pharmaceuticals have increased by 17.99% increased compared to the previous year.

What are the consequences of high debt for investors of X4 Pharmaceuticals?

High liabilities can pose a risk for investors of X4 Pharmaceuticals, as they can weaken the company's financial position and impair its ability to meet its obligations.

What consequences do low liabilities have for investors in X4 Pharmaceuticals?

Low liabilities mean that X4 Pharmaceuticals has a strong financial position and is able to meet its obligations without overburdening its finances.

How does an increase in liabilities of X4 Pharmaceuticals affect the company?

An increase in liabilities of X4 Pharmaceuticals can lead to the company having more obligations and potentially find it more difficult to meet its financial commitments.

How does a reduction in the liabilities of X4 Pharmaceuticals affect the company?

A decrease in the liabilities of X4 Pharmaceuticals can lead to the company having fewer obligations and a stronger financial position, which can make it easier for the company to fulfill its financial commitments.

What are some factors that influence the liabilities of X4 Pharmaceuticals?

Some factors that can influence the liabilities of X4 Pharmaceuticals include investments, acquisitions, operating costs, and sales development.

Why is the level of liabilities of X4 Pharmaceuticals so important for investors?

The liabilities of X4 Pharmaceuticals are important for investors as they serve as an indicator of the company's financial stability and provide investors with information on how the company meets its financial obligations.

What strategic measures can X4 Pharmaceuticals take to modify the liabilities?

To change its liabilities, X4 Pharmaceuticals can take measures such as cost savings, increasing revenue, selling assets, raising investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to choose the best strategic actions.

How much dividend does X4 Pharmaceuticals pay?

Over the past 12 months, X4 Pharmaceuticals paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, X4 Pharmaceuticals is expected to pay a dividend of 0 USD.

What is the dividend yield of X4 Pharmaceuticals?

The current dividend yield of X4 Pharmaceuticals is .

When does X4 Pharmaceuticals pay dividends?

X4 Pharmaceuticals pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of X4 Pharmaceuticals?

X4 Pharmaceuticals paid dividends every year for the past 0 years.

What is the dividend of X4 Pharmaceuticals?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is X4 Pharmaceuticals located?

X4 Pharmaceuticals is assigned to the 'Health' sector.

Wann musste ich die Aktien von X4 Pharmaceuticals kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of X4 Pharmaceuticals from 5/16/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 5/16/2024.

When did X4 Pharmaceuticals pay the last dividend?

The last dividend was paid out on 5/16/2024.

What was the dividend of X4 Pharmaceuticals in the year 2023?

In the year 2023, X4 Pharmaceuticals distributed 0 USD as dividends.

In which currency does X4 Pharmaceuticals pay out the dividend?

The dividends of X4 Pharmaceuticals are distributed in USD.